Fig. 2.

High NCALD expression predicts worse survival of allo-HSCT or post-chemotherapy AML patients from the TCGA dataset. The X axis represents time (months) and the Y axis represents survival probability. A, Kaplan–Meier curves were used of EFS and OS in different NCALD expression groups after allo-HSCT. The cutoff value for the high and low NCALD groups was 5.30. EFS, P = 0.0051; OS, P = 0.028; log rank test. B, Kaplan–Meier curves were used of EFS and OS in different NCALD expression group after chemotherapy. The cutoff value for the high and low NCALD groups was 4.66. EFS, P = 0.011; OS, P = 0.0056; log rank test